Back to Journals » Vascular Health and Risk Management » Volume 12

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Total article views   Abstract views HTML views PDF downloads Totals
13,112 Dovepress* 6,743 2,913+ 2,168 9,656
PubMed Central* 0 3,456 1,030 3,456
Totals 6,743 6,369 3,198 13,112
*Since 9 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar